GB1322301A - Purine-ribonucleoside derivatives - Google Patents
Purine-ribonucleoside derivativesInfo
- Publication number
- GB1322301A GB1322301A GB490872A GB490872A GB1322301A GB 1322301 A GB1322301 A GB 1322301A GB 490872 A GB490872 A GB 490872A GB 490872 A GB490872 A GB 490872A GB 1322301 A GB1322301 A GB 1322301A
- Authority
- GB
- United Kingdom
- Prior art keywords
- purine
- ribonucleosides
- feb
- general formula
- ribonucleoside derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1322301 Purine-ribonucleosides BOEHRINGER MANNHEIM GmbH 2 Feb 1972 [6 Feb 1971] 4908/72 Heading C2C Novel purine-ribonucleoside derivatives of the general formula wherein R 1 is hydroxy or amino and R 2 is hydrogen or halogen, are prepared by nitrating purine-ribonucleosides of the general formula Pharmaceutical compositions having cardiac activity contain the above novel compounds and may be administered enterally or parenterally in admixture with solid or liquid carriers and may be in the form of tablets, capsules, dragees, syrups, solutions and suspensions.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19712105560 DE2105560A1 (en) | 1971-02-06 | 1971-02-06 | Purine ribonucleoside derivatives and processes for making the same |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1322301A true GB1322301A (en) | 1973-07-04 |
Family
ID=5797950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB490872A Expired GB1322301A (en) | 1971-02-06 | 1972-02-02 | Purine-ribonucleoside derivatives |
Country Status (4)
Country | Link |
---|---|
AT (1) | AT312816B (en) |
CH (1) | CH565815A5 (en) |
DE (1) | DE2105560A1 (en) |
GB (1) | GB1322301A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2226295A1 (en) * | 1972-05-30 | 1973-12-20 | Henning Berlin Gmbh | NITRIC ACID ESTERS OF PURIN NUCLEOSIDES AND METHOD FOR MANUFACTURING THE SAME |
AT350735B (en) * | 1976-08-06 | 1979-06-11 | Hoffmann La Roche | METHOD FOR PRODUCING NEW RIBO-FURANOSYL IMIDAZOLE DERIVATIVES |
FR2684997A1 (en) * | 1991-12-12 | 1993-06-18 | Centre Nat Rech Scient | DERIVATIVES OF 9- (BETA-D-XYLOFURANNOSYL) ADENINE AND 1- (BETA-D-XYLOFURANNOSYL) CYTOSINE, THEIR PREPARATION AND THEIR THERAPEUTIC USE. |
-
1971
- 1971-02-06 DE DE19712105560 patent/DE2105560A1/en active Pending
-
1972
- 1972-02-02 GB GB490872A patent/GB1322301A/en not_active Expired
- 1972-02-03 CH CH158372A patent/CH565815A5/xx not_active IP Right Cessation
- 1972-02-04 AT AT89472A patent/AT312816B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE2105560A1 (en) | 1972-09-07 |
CH565815A5 (en) | 1975-08-29 |
AT312816B (en) | 1974-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1002531A (en) | Derivatives of 2-oxa-1,1,3-propanetricarboxylic acid and 2-oxa-1,1,3,3-propanetetracarboxylic acid | |
CA989864A (en) | Metal derivatives of 3,5-di-t-butyl-hydroxyphenylpropionic acid and compositions containing these derivatives | |
GB1392275A (en) | Therapeutic compositions | |
GB1263000A (en) | 4,4',4''-trihydroxytriphenylmethylmethane and process for preparing it | |
GB1386150A (en) | 6-acylaminophenyl-4,5-dihydropyridazones | |
GB1322301A (en) | Purine-ribonucleoside derivatives | |
GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
GB1368375A (en) | 4-/4-biphenylzl/-1-butanols | |
IL70124A (en) | 5,14-dihydrobenz(5,6)isoindolo(2,1-b)isoquinoline-8,13-dione,its preparation and pharmaceutical compositions containing it | |
GB1252286A (en) | ||
ES427115A1 (en) | Novel benzoylphenylacetic acid derivatives | |
GB1283632A (en) | Phenylethanolamine derivatives | |
GB1511196A (en) | Creatinine pyrolidonecarboxylate | |
GB1356898A (en) | Pyrazino-1,2-a-indole-2-carboxamidines and processes for their preparation | |
GB1346706A (en) | Substituted cysteines and the production thereof | |
GB1361779A (en) | Vincamine salt and its use as a pharmaceutical composition | |
GB1390650A (en) | Oxazines and thiazines | |
GB1271122A (en) | New azabicycloalkylurea derivatives and process for preparing them | |
GB1332635A (en) | Rutin complexes | |
GB1243955A (en) | Novel n-substituted amines and their process of preparation | |
GB1290468A (en) | ||
GB1438218A (en) | Indole derivatives | |
GB1336632A (en) | Salts of para-chlorophenoxyisobutyric acid their preparation and pharmaceutical compositions containing them | |
AU3810972A (en) | Process forthe preparation of 1, 4 benzothiazepines | |
GB1127748A (en) | Pharmaceutical compositions for use in the treatment of disturbances due to luteinic deficiency |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |